⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Clinical Outcomes Solutions and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Clinical Outcomes Solutions
↗Chicago, USA / Folkestone, UK
Clinical Outcomes Solutions (COS) is a specialized health economics and outcomes research (HEOR) consulting group. The company focuses on Clinical Outcome Assessments (COA), providing strategic and regulatory advice to help clients capture the patient voice in clinical trials and inform value-driven healthcare decisions.
Founded in 2013, the firm offers expertise in Patient-Reported Outcomes (PROs), Clinician-Reported Outcomes (CROs), and observer-reported outcomes. In 2021, the company was acquired by Validant, a global quality, compliance, and regulatory consulting firm, to enhance its service offerings in the clinical research space.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Health Economics and Outcomes Research (HEOR)
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$20M
Founded:2013
Ownership:subsidiary
Status:acquired
0
CORPORATE STRUCTURE
Parent Company:Validant
Acquired By:Validant (2021-05-01)
Key Partnerships:BioSpark AI Technologies Inc. (Collaboration on COA-AI software)
COMPETITION
Position:Niche Player
Competitors:Evidera, Adelphi Values, ICON plc, IQVIA
LEADERSHIP
Key Executives:
Fabian Cordova - CEO
Stacie Hudgens - Chief Scientific & Strategy Officer
Tara Symonds - Chief Scientific Officer
LINKS
Website:clinoutsolutions.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Clinical Outcomes Solutions. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.